Julia Mestre

6PUBLICATIONS
21CO-AUTHORS
Predictive and prognostic markersMedical biotechnology diagnostics (incl. biosensors)Medical mycologyHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jul 10, 2026
Germline landscape stratification defines distinct molecular and prognostic groups in therapy related myeloid neoplasms.

|May 04, 2026
Different SF3B1 Mutation Hotspots Show Hematopoietic Lineage-Specific VAF Patterns and Correlate with Distinct Genetic and Prognostic Profiles in Patients with Myeloid Neoplasms.

|Jun 11, 2025
Integrated cytogenetic and genomic profiling of the MDS-L cell line.

Julia Mestre, Lorea Chaparro-González, Isabel Granada

|Oct 17, 2024
Beyond myeloid neoplasms germline guidelines: Validation of the thresholds criteria in the search of germline predisposition variants.

Julia Mestre, Lorea Chaparro, Ana Manzanares

|Dec 23, 2023
Two-Time Multiplexed Targeted Next-Generation Sequencing Might Help the Implementation of Germline Screening Tools for Myelodysplastic Syndromes/Hematologic Neoplasms.

Oriol Calvete, Julia Mestre, Ruth M Risueño

|Mar 11, 2023
The Secondary Myelodysplastic Neoplasms (MDS) Jigsaw.

Oriol Calvete, Julia Mestre, Andrés Jerez

Pageof 1

Frequent Collaborators

5 joint publications

Francesc Solé

3 joint publications

Oriol Calvete

3 joint publications

Blanca Xicoy

3 joint publications

Lurdes Zamora